Recurrence is a common sequela of Clostridium difficile -associated diarrhea (CDD) and may increase morbidity, costs, and treatment-related antimicrobial resistance. Because recurrent CDD (RCDD) frequently occurs very soon after an initial episode, our goal was to determine the risk factors for early RCDD (occurring £45 days after the initial episode). We conducted a case-control study, comparing 13 patients with early RCDD (case patients) with 46 patients who had only one CDD episode (control patients) at Centre Hospitalier Angrignon (Québec) during January 1993 through November 1994. Risk factors for early RCDD included a history of chronic renal insufficiency, a white blood cell count of §15 1 10 3 /mm 3 , and community-acquired diarrhea with the first CDD episode. For seven of eight case patients, C. difficile strains from the first and second CDD episodes were identical, suggesting that relapse is more common than reinfection. These results suggest that treatments should be directed at preventing relapses in patients at high risk for early RCDD.
Clostridium difficile has been recognized as the major cause there may be underlying host factors predisposing certain patients to RCDD. Many patients experience recurrence very of nosocomial gastroenteritis [1] . Illness usually is induced by antimicrobials, which disturb the balance of normal colonic early after the initial episode [2, 16 -18] , suggesting that injuries from the initial CDD episode also may influence the risk microflora and allow C. difficile overgrowth. Although treatable, C. difficile -associated diarrhea (CDD) tends to recur in for RCDD. To better understand these characteristics of RCDD, we examine the risk factors for early RCDD among patients many patients. Recurrence rates are frequently reported to be 10% -20% but may be as high as 65% in patients with one presenting with their first episode of CDD. CDD episode [2, 3] . Some patients suffer multiple recurrences, regardless of the therapies received, which may range from Methods administration of conventional oral antimicrobials to more exDefinitions treme measures, like the use of fecal enemas to restore the To determine the risk factors for early RCDD, we conducted normal colonic flora [4 -15] .
a case-control study, comparing the clinical characteristics of No treatment approach has been shown to prevent RCDD patients who had at least two CDD episodes (i.e., case patients) satisfactorily. However, because knowledge about risk factors with those who had only one CDD episode (i.e., control pafor RCDD is still lacking, it may be difficult to see the full tients) at Centre Hospitalier Angrignon (CHA; Verdun, Qué-impact of some of the treatments that have been evaluated. bec, Canada) during the study period, January 1993 through The identification of risk factors is also important in underNovember 1994. CDD was defined as the occurrence of diarstanding the pathogenesis of RCDD, which would guide the rhea in association with a C. difficile -positive stool culture and selection of other suitable treatments for evaluation.
no other identifiable causes of diarrhea. Diarrhea was defined as In a recently published report, a history of multiple RCDD §2 documented loose stools for at least 2 days; resolution was episodes was identified as an important risk factor for subsedefined as normal stool frequency and consistency for at least quent RCDD, although the severity of CDD did not increase 3 consecutive days. Diarrhea that began before or £48 hours with subsequent episodes [2] . This finding suggests that, despite after hospital admission was defined as community-acquired the bowel's ability to recover from an initial CDD episode, CDD. Early RCDD was defined as a second CDD episode occurring within 45 days after onset of the first CDD episode. Control patients were randomly selected from among all pa- Multivariate analysis was performed with forward stepwise discharge. The patients' underlying health status was assessed logistic regression on PC-SAS software [25] . For our multivariby reviewing medical records for chronic illnesses and calculatate model, we included factors that were most strongly associing a comorbidity index score [20] . The presence of a chronic ated with early RCDD in the univariate analysis. underlying illness was defined as any documentation of the illness during the hospitalization and around the time of the first CDD episode.
Results We compared the characteristics of case and control patients
Culture Results
during two time periods (figure 1). The first period was defined as the 45 days before onset of the initial CDD episode for both During the study period, C. difficile was isolated from 267 case and control patients. The second period, for case patients, stool specimens of 198 patients at CHA. A total of 24 (56%) was the interval from onset of the first CDD episode until onset had a second episode of CDD within 45 days after onset of of the second CDD episode; for control patients, it was the the first episode. Of the 24 potential case patients, 13 met our interval from onset of the only CDD episode until discharge definition for early RCDD. From among the remaining 175 or 45 days, whichever came first. patients, we randomly selected 100 control patients, 46 of During the first period, we compared case and control pawhom met our definition for CDD. tients' exposures to medications such as antimicrobials, chemotherapeutic agents, steroids, and antacids. During the second
Characteristics of Case Patients
period, we compared case and control patients' exposures to medications and to procedures such as surgeries, endoscopy, The 13 case patients were those with a history of chronic and nasogastric tube placement. Because the severity of the renal insufficiency (n Å 6) or community-acquired CDD first CDD episode also may influence the risk for an early (n Å 6); one case patient had both conditions. The median age recurrence, factors relating to the severity of the first CDD of the 13 case patients was 77 (range, 28 -92) years, and the episode (e.g., APACHE-II score, fever [temperature of median comorbidity index score was 4 (range, 1 -7 
NOTE. NT Å not tested; / Å positive; 0 Å negative. * Centers for Disease Control and Prevention's assigned codes.
or chemotherapy. During the first CDD episode, 4 case patients acquired CDD with the first episode, but these associations did not reach statistical significance (table 2) . (31%) had documented evidence of colitis; 3 of these 4 had pseudomembranous colitis. Two case patients died, but CDD In multivariate analysis, the risk factors for recurrent CDD were a history of chronic renal insufficiency (OR, 17.1; was not a direct cause of death.
Isolates from five case patients were subjected to antimicrobial P õ .01), a high WBC count (i.e., §15 1 10 3 /mm 3 ) at onset of the initial CDD episode (OR, 11.3; P õ .01), or presentation susceptibility testing, and all isolates were susceptible to all antimicrobials tested, including metronidazole and vancomycin.
with community-acquired CDD during the initial episode (OR, 11.2; P Å .02). For the majority of patients, toxin A or B testing results from the first and second CDD episodes were similar (table 1) .
Among eight case patients with isolates available from both
Patients with Chronic Renal Insufficiency or Community-
CDD episodes, six different C. difficile strain types were identi-
Acquired CDD
fied. For seven of these eight case patients, the same strain type was identified in the first and second CDD episodes (table 1) . Because of the substantial influence of these factors on the risk for RCDD, we examined more closely the CDD patients with a history of chronic renal insufficiency and those with community-acquired CDD separately, in order to better charac-
Risk Factors for Recurrence
terize these patients.
A total of 15 patients in our study had a reported history of In our univariate analysis, case and control patients did not differ significantly in terms of age, sex, comorbidity index chronic renal insufficiency. At the time of their initial CDD episode, the 15 patients had serum creatinine levels of §1.5 score, or most underlying chronic conditions, although case patients were more likely than control patients to have had a mg/dL; for 10, the levels were §2.0 mg/dL (2 of them were undergoing hemodialysis). Compared with other CDD patients history of chronic renal insufficiency (table 2). There also was no significant difference in exposures to antimicrobials (table in our study, those with a history of chronic renal insufficiency had more underlying illnesses, as reflected by a significantly 3) or other medications during either period of comparison.
With regard to the clinical course of the first CDD episode, higher comorbidity index score (median, 6 vs. 3; P õ .01) and longer hospitalization time (median, 113 vs. 31 days; P õ .01), case and control patients did not differ significantly in terms of APACHE-II scores, presence of fever, maximum stooling but there was no significant difference in the clinical CDD illness (i.e., duration of diarrhea, occurrence of nausea/vomfrequency, initial CDD therapy, or CDD treatment failure. However, case patients were significantly more likely than coniting and abdominal cramping, and stooling frequency). A total of 19 study patients met our definition for commutrol patients to have had a high WBC count (i.e., §15 1 10 3 /mm 3 ) at onset of the initial CDD episode. Case patients also nity-acquired CDD with their initial diarrhea episode. Of these 19 patients, 13 had been hospitalized previously, with a median were more likely to have had documented colitis or community-/ 9c4a$$ap62 03-09-98 18:23:05 cidal UC: CID / 9c4a$$ap62 03-09-98 18:23:05 cidal UC: CID time of 34 days between hospitalizations; of the 6 patients who Along with the poor underlying health conditions, there may have been malnutrition and immunologic impairment, which had not previously been hospitalized, 5 had had antimicrobial exposure before the initial CDD episode. Compared with other may increase the risk for infections; in addition, antimicrobial therapy for the infections, over time, may result in an altered CDD patients in our study, those with community-acquired CDD had a lower comorbidity index score (median, 2 vs. 5; bowel microflora, favoring C. difficile growth. For some patients, vascular insufficiency also may be associated with a P õ .01) and shorter hospitalization time (median, 19 vs. 54 days; P õ .01); however, patients with community-acquired poor underlying health status and may result in low-grade ischemia and chronic insult to the bowel, leading to increased CDD appeared to have a more severe clinical CDD illness, with longer duration of diarrhea (median, 17 vs. 8 days; susceptibility to C. difficile disease. Thus, a number of different host factors may explain the increased risk for RCDD in our P Å .04), more nausea/vomiting and abdominal cramping (OR, 4.1; P Å .05), and a slightly higher stooling frequency (median, patients with a history of chronic renal insufficiency; however, whether or not the risk for RCDD is related to any degree of 6 vs. 5 stools per day; P õ .01).
renal impairment is not known and requires more detailed studies of patients with renal disease. In contrast to the CDD patients with a history of chronic Discussion renal insufficiency, the patients who met our definition for community-acquired CDD did not have multiple underlying Currently, the focus of preventing CDD is directed on reducing cross-contamination by isolating infected patients appropriconditions predisposing them to repeated infections and requiring chronic hospitalization. However, compared with other ately and emphasizing good infection control techniques [26] . Although these measures are effective in controlling nosoco-CDD patients, our patients with community-acquired CDD had a more severe initial illness, which may leave the bowel more mial transmission during outbreaks of CDD, their direct impact on RCDD is not known. Possible mechanisms for RCDD are vulnerable to subsequent RCDD. Factors that may lead to a severe initial episode include delayed diagnosis, delayed initiareinfection from the external environment or germination of persistent spores in the gastrointestinal tract [3] ; if RCDD oction of appropriate therapy, and self-treatment with antidiarrheal drugs [37, 38] , antimicrobials, or other types of medicacurs by relapse rather than reinfection, other measures, in addition to good infection control techniques, may be necessary to
tions. An increased awareness by clinicians about the possibility of CDD outside the hospital setting, therefore, may decrease the risk of recurrence.
Several earlier studies involving strain typing of C. difficile reduce the risk for early RCDD. Additional evidence suggesting the influence of a severe first isolates from patients with RCDD have shown evidence suggesting that reinfection occurs more frequently than relapse CDD episode on the risk for early recurrence is in our finding that a high WBC count was independently predictive of RCDD. [27, 28] . In these studies, however, there was little distinction in the timing of recurrence; RCDD episodes occurring early A systemic illness is suggested by the increased WBC count. Localized gastrointestinal signs and symptoms of CDD, such were considered together with RCDD episodes occurring months to years after the initial CDD episode. Using a more as the maximum stooling frequency or the overall duration of diarrhea, were not predictive of early RCDD. specific definition of recurrence (i.e., a CDD episode occurring within 45 days after onset of the first CDD episode), we found
In conclusion, host factors appear to be more important than the C. difficile strain types in the development of early RCDD. that the same strain type was isolated during the first and second CDD episodes for seven of eight case patients, suggesting that Our molecular strain typing results show no predominant strain types among case patients and suggest that the mechanism for relapse is the predominant mechanism for early RCDD. Although any one patient could be reinfected with the same early RCDD was relapse more often than reinfection. Although current preventive strategies for CDD are based on reducing C. difficile strain, this is not likely among the eight patients with six different strain types.
cross-infection, which would decrease the risk of RCDD through reinfection, our data suggest that future studies evaluatThe lack of a predominant strain type among our case patients also suggests that, in the pathogenesis of early RCDD, host facing preventive and treatment strategies should focus more on patients at high risk for RCDD through relapses, such as those tors may be more important than the specific C. difficile strain types. A patient's underlying health status or the severity of the with a history of chronic renal insufficiency or those who have a severe initial CDD episode, as suggested by a high WBC initial CDD illness may contribute to the risk for early RCDD.
In previous studies, there was evidence that uremic patients count or the presentation of community-acquired CDD. are at risk for C. difficile diseases [29] [30] [31] [32] [33] [34] [35] [36] . In our study, however, the range of renal impairment seemed wide among patients with a reported history of chronic renal insufficiency, and uremia does
